Suppr超能文献

2-(对氯苯氧基)丁酸(CPB)对电鳐氯通道ClC-0单个原孔的阻断机制。

Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB).

作者信息

Pusch M, Accardi A, Liantonio A, Ferrera L, De Luca A, Camerino D C, Conti F

机构信息

Istituto di Cibernetica e Biofisica, Consiglio Nazionale delle Ricerche, I-6149 Genova, Italy.

出版信息

J Gen Physiol. 2001 Jul;118(1):45-62. doi: 10.1085/jgp.118.1.45.

Abstract

We investigated in detail the mechanism of inhibition by the S(-) enantiomer of 2-(p-chlorophenoxy)butyric acid (CPB) of the Torpedo Cl(-)channel, ClC-0. The substance has been previously shown to inhibit the homologous skeletal muscle channel, CLC-1. ClC-0 is a homodimer with probably two independently gated protopores that are conductive only if an additional common gate is open. As a simplification, we used a mutant of ClC-0 (C212S) that has the common gate "locked open" (Lin, Y.W., C.W. Lin, and T.Y. Chen. 1999. J. Gen. Physiol. 114:1-12). CPB inhibits C212S currents only when applied to the cytoplasmic side, and single-channel recordings at voltages (V) between -120 and -80 mV demonstrate that it acts independently on individual protopores by introducing a long-lived nonconductive state with no effect on the conductance and little effect on the lifetime of the open state. Steady-state macroscopic currents at -140 mV are half-inhibited by approximately 0.5 mM CPB, but the inhibition decreases with V and vanishes for V > or = 40 mV. Relaxations of CPB inhibition after voltage steps are seen in the current responses as an additional exponential component that is much slower than the gating of drug-free protopores. For V = 60 mV) with an IC50 of approximately 30-40 mM. Altogether, these findings support a model for the mechanism of CPB inhibition in which the drug competes with Cl(-) for binding to a site of the pore where it blocks permeation. CPB binds preferentially to closed channels, and thereby also strongly alters the gating of the single protopore. Since the affinity of CPB for open WT pores is extremely low, we cannot decide in this case if it acts also as an open pore blocker. However, the experiments with the mutant K519E strongly support this interpretation. CPB block may become a useful tool to study the pore of ClC channels. As a first application, our results provide additional evidence for a double-barreled structure of ClC-0 and ClC-1.

摘要

我们详细研究了2-(对氯苯氧基)丁酸(CPB)的S(-)对映体对电鳐Cl(-)通道ClC-0的抑制机制。此前已表明该物质可抑制同源的骨骼肌通道CLC-1。ClC-0是一种同二聚体,可能有两个独立门控的原孔,只有当一个额外的共同门打开时才具有导电性。为简化起见,我们使用了ClC-0的一个突变体(C212S),其共同门“锁定打开”(林育文、林聪伟和陈天佑,1999年,《普通生理学杂志》114:1 - 12)。CPB仅在应用于细胞质侧时才抑制C212S电流,在-120至-80 mV之间的电压(V)下进行的单通道记录表明,它通过引入一种长寿命的非导电状态独立作用于单个原孔,对电导无影响,对开放状态的寿命影响很小。在-140 mV时的稳态宏观电流约0.5 mM CPB可使其减半抑制,但抑制作用随电压降低,在V≥40 mV时消失。电压阶跃后CPB抑制的弛豫在电流响应中表现为一个额外的指数成分,其比无药物原孔的门控慢得多。对于V = 60 mV,IC50约为30 - 40 mM。总之,这些发现支持了CPB抑制机制的模型,即药物与Cl(-)竞争结合孔道中的一个位点,在该位点它阻断通透。CPB优先结合关闭的通道,从而也强烈改变单个原孔的门控。由于CPB对开放的野生型孔道的亲和力极低,在这种情况下我们无法确定它是否也作为开放孔道阻滞剂起作用。然而,对突变体K519E的实验有力地支持了这一解释。CPB阻断可能成为研究ClC通道孔道的有用工具。作为第一个应用,我们的结果为ClC-0和ClC-1的双桶结构提供了额外证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0178/2233749/84f707178f3d/JGP8425.s1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验